标题
The metabolic and mitogenic properties of basal insulin analogues
作者
关键词
-
出版物
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Volume 119, Issue 1, Pages 1-14
出版商
Informa UK Limited
发表日期
2013-02-04
DOI
10.3109/13813455.2012.754474
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Plasma Exposure to Insulin Glargine and Its Metabolites M1 and M2 After Subcutaneous Injection of Therapeutic and Supratherapeutic Doses of Glargine in Subjects With Type 1 Diabetes
- (2012) G. B. Bolli et al. DIABETES CARE
- Metabolism of Insulin Glargine After Repeated Daily Subcutaneous Injections in Subjects With Type 2 Diabetes
- (2012) P. Lucidi et al. DIABETES CARE
- Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly
- (2012) A. J. Varewijck et al. DIABETOLOGIA
- Insulin glargine and risk of cancer: a cohort study in the French National Healthcare Insurance Database
- (2012) P. Blin et al. DIABETOLOGIA
- Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Design of the Novel Protraction Mechanism of Insulin Degludec, an Ultra-long-Acting Basal Insulin
- (2012) Ib Jonassen et al. PHARMACEUTICAL RESEARCH
- Insulin glargine use and short-term incidence of malignancies — a three-year population-based observation
- (2011) Rickard Ljung et al. ACTA ONCOLOGICA
- Safety of Insulin Glargine Use in Pregnancy: A Systematic Review and Meta-Analysis
- (2011) Erika Pollex et al. ANNALS OF PHARMACOTHERAPY
- Complete Diabetes Protection Despite Delayed Thymic Tolerance in NOD8.3 TCR Transgenic Mice Due to Antigen-Induced Extrathymic Deletion of T Cells
- (2011) B. Krishnamurthy et al. DIABETES
- Further Exploration of the Relationship Between Insulin Glargine and Incident Cancer: A retrospective cohort study of older Medicare patients
- (2011) N. E. Morden et al. DIABETES CARE
- Differential Effects of Adiposity on Pharmacodynamics of Basal Insulins NPH, Glargine, and Detemir in Type 2 Diabetes Mellitus
- (2011) F. Porcellati et al. DIABETES CARE
- Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
- (2011) T. P. van Staa et al. DIABETOLOGIA
- Long-term effects of insulin glargine on the risk of breast cancer
- (2011) S. Suissa et al. DIABETOLOGIA
- Risk of cancer in patients on insulin glargine and other insulin analogues in comparison with those on human insulin: results from a large population-based follow-up study
- (2011) R. Ruiter et al. DIABETOLOGIA
- Controversies in the use of insulin analogues
- (2011) Haim Werner et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Cancer Risk Associated with Insulin Glargine among Adult Type 2 Diabetes Patients – A Nationwide Cohort Study
- (2011) Chia-Hsuin Chang et al. PLoS One
- The relationship between the exposure time of insulin glargine and risk of breast and prostate cancer: An observational study of the time-dependent effects of antidiabetic treatments in patients with diabetes
- (2011) Marcus Lind et al. Primary Care Diabetes
- Growth effects of insulin and insulin analogues
- (2011) Juergen Sandow ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- Insulin and its analogs: actions via insulin and IGF receptors
- (2010) R. Vigneri et al. ACTA DIABETOLOGICA
- Diabetes and Cancer: A Consensus Report
- (2010) E. Giovannucci et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
- (2010) E. Mannucci et al. DIABETES CARE
- Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor
- (2010) E. Yehezkel et al. DIABETOLOGIA
- Insulin analogues differently activate insulin receptor isoforms and post-receptor signalling
- (2010) L. Sciacca et al. DIABETOLOGIA
- Metformin: Taking away the candy for cancer?
- (2010) Mathilde Jalving et al. EUROPEAN JOURNAL OF CANCER
- Review on the In Vitro Interaction of Insulin Glargine with the Insulin/Insulin-like Growth Factor System: Potential Implications for Metabolic and Mitogenic Activities
- (2010) T. Ciaraldi et al. HORMONE AND METABOLIC RESEARCH
- Comparison of intracellular signalling by insulin and the hypermitogenic AspB10 analogue in MCF-7 breast adenocarcinoma cells
- (2010) Martin B. Oleksiewicz et al. JOURNAL OF APPLIED TOXICOLOGY
- In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites
- (2010) Mark R. Sommerfeld et al. PLoS One
- Insulin Glargine and NPH Insulin Increase to a Similar Degree Epithelial Cell Proliferation and Aberrant Crypt Foci Formation in Colons of Diabetic Mice
- (2010) Jutta M. Nagel et al. Hormones & Cancer
- A robust assay measuring GLUT4 translocation in rat myoblasts overexpressing GLUT4-myc and AS160_v2
- (2009) Daniela Baus et al. ANALYTICAL BIOCHEMISTRY
- Insulin Glargine Safety in Pregnancy: A transplacental transfer study
- (2009) E. K. Pollex et al. DIABETES CARE
- Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
- (2009) Doron Weinstein et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine
- (2009) J. M. Nagel et al. DIABETOLOGIA
- Combined randomised controlled trial experience of malignancies in studies using insulin glargine
- (2009) P. D. Home et al. DIABETOLOGIA
- Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
- (2009) J. Rosenstock et al. DIABETOLOGIA
- Similar progression of diabetic retinopathy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: a long-term, randomised, open-label study
- (2009) J. Rosenstock et al. DIABETOLOGIA
- Does diabetes therapy influence the risk of cancer?
- (2009) U. Smith et al. DIABETOLOGIA
- Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden
- (2009) J. M. Jonasson et al. DIABETOLOGIA
- No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
- (2009) A. Dejgaard et al. DIABETOLOGIA
- Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
- (2009) H. M. Colhoun et al. DIABETOLOGIA
- The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
- (2009) C. J. Currie et al. DIABETOLOGIA
- Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
- (2009) L. G. Hemkens et al. DIABETOLOGIA
- Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
- (2009) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines
- (2009) Ashish Shukla et al. ENDOCRINE-RELATED CANCER
- Insulin glargine and malignancy: an unwarranted alarm
- (2009) Stuart J Pocock et al. LANCET
- Characteristics of signalling properties mediated by long-acting insulin analogue glargine and detemir in target cells of insulin
- (2008) Tsutomu Wada et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Proliferative effects of insulin analogues on mammary epithelial cells
- (2008) Doris Mayer et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started